Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 6, 2012, Pages 494-497

  Leblebisatan, Goksel ^a   Bay, Ali ^c   Karakus, Suleyman C ^a   Kekilli, Murat ^b   Haznedaroglu, Ibrahim C ^d  

^a Gaziantep Children Hospital   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Ankaferd; bleeding; children

Indexed keywords

ANKAFERD BLOOD STOPPER; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR CONCENTRATE; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GLANZMANN DISEASE; HEMOPHILIA A; HUMAN; HYPOFIBRINOGENEMIA; INFANT; MALE; ORAL BLEEDING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGIC DISORDERS; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; INFANT; MALE; MOUTH; ORAL HEMORRHAGE; PLANT EXTRACTS; TURKEY;

EID: 84865515526     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834fa837     Document Type: Article

References (35)

1. Brewer A, Correa ME. Guidelines for dental treatment of patients with inherited bleeding disorders. Treatment of Hemophilia monograph no. 40. World Federation of Hemophilia, 2006.
2. Ak G, Cakir O, Kazancioglu HO, Zulfikar B. The use of a new hemostatic agent: Ankaferd Blood Stopper in hemophiliacs. Haemophilia 2010; 16:51-151.
3. Baykul T, Alanoglu EG, Kocer G. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. J Contemp Dent Pract 2010; 11:E088-E094.
4. Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 2010; 267:1377-1381.
5. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol 2009; 73:1742-1745.
6. Yarali N, Oruc M, Bay A, Dalgic B, Bozkaya IO, Ankoglu T, et al. A new hemostatic agent: Ankaferd blood stopper - management of gastrointestinal bleeding in an infant and other experiences in children. Pediatr Hematol Oncol 2010; 27:592-596.
7. Demiralp DO, Haznedaroglu IC, Akar N. Functional proteomic analysis of Ankaferd (R) Blood Stopper. Turk J Hematol 2010; 27:70-77.
8. Haznedaroglu IC. Molecular basis of the pleiotropic effects of Ankaferd Blood Stopper. IUBMB Life 2009; 61:290-1290.
9. Aydin S. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2009; 37:279.
10. Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H,Goker H, Kosar A, et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost 2010; 16:446-453.
11. Huri E, Akgul T, Ayyildiz A, Bagcioglu M, Germiyanoglu C. First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy. Kaohsiung J Med Sci 2010; 26:493-495.
12. Huri E, Akgul T, Ayyildiz A, Germiyanoglu C. Hemostasis in retropubic radical prostatectomy with Ankaferd BloodStopper: a case report. Kaohsiung J Med Sci 2009; 25:445-447.
13. Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J 2010; 30:864-868.
14. Karaman A, Torun E, Gursoy S, Yurci A, Ozbakir O. Efficacy of Ankaferd Blood Stopper in postpolypectomy bleeding. J Altern Complement Med 2010; 16:1027-1028.
15. Karaman K, Bostanci EB, Ercan M, Kurt M, Teke Z, Reyhan E, Akoglu M. Topical Ankaferd application to presacral bleeding due to total mesorectal excision in rectal carcinoma. J Invest Surg 2010; 23:175.
16. Kurt M, Akdogan M, Onal IK, Kekilli M, Arhan M, Shorbagi A, et al. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis. Dig Liver Dis 2010; 42:196-199.
17. Kurt M, Disibeyaz S, Akdogan M, Sasmaz N, Aksu S, Haznedaroglu IC. Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol 2008; 103:2156-2158.
18. Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008; 40 (Suppl 2):E262.
19. Kurt M, Onal I, Akdogan M, Kekilli M, Arhan M, Sayilir A, et al. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Can J Gastroenterol 2010; 24:380-384.
20. Kurt M, Oztas E, Kuran S, Onal IK, Kekilli M, Haznedaroglu IC. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med 2009; 27:631.e1-631.e2.
21. Ozaslan E, Purnak T, Yildiz A, Akar T, Avcioglu U, Haznedaroglu IC. The effect of Ankaferd blood stopper on severe radiation colitis. Endoscopy 2009; 41 (Suppl 2):E321-E322.
22. Ozaslan E, Purnak T, Ozyigit G, Akyol F, Yildiz A, Haznedaroglu IC. No prolonged effect of Ankaferd Blood Stopper on chronic radiation proctitis. Endoscopy 2010; 42 (Suppl 2):E271-E272.
23. Ozaslan E, Purnak T, Tenlik I, Yildiz A, Haznedaroglu IC. An alternative hemostatic method for early GI bleeding caused by anastomotic ulcer. Gastrointest Endosc 2010; 72:902-903.
24. Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Indian J Gastroenterol 2010; 29:166-168.
25. Sonmez M, Baltacioglu E, Sarac O, Erkut N. The use of Ankaferd blood stopper in a patient with Glanzmann's thrombasthenia with gingival bleeding. Blood Coagul Fibrinolysis 2010; 21:382-383.
26. Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc 2010; 71:873-875.
27. Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of nonvariceal gastrointestinal bleeding: Ankaferd blood stopper. Hepatogastroenterology 2010; 57:191-194.
28. Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd blood stopper. Dig Liver Dis 2010; 42:594-595.
29. Akkoc N, Akcelik M, Haznedaroglu IC, Goker H, Turgut M, Aksu S, et al. In vitro anti-bacterial activities of Ankaferd medicinal plant extract. Turkiye Klinikleri Tip Bilimleri Dergisi 2009; 29:410-415.
30. Ercetin S, Haznedaroglu IC, Kurt M, Onal IK, Aktas A, Kurt OK, et al. Safety and efficacy of Ankaferd Blood Stopper in dental surgery. Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi 2010; 20:1-5.
31. Isler SC, Demircan S, Cakarer S, Cebi Z, Keskin C, SolukM, Yuzbasioglu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18:409-414.
32. Oner AF, Dogan M, Kaya A, Sal E, Bektas MS, Yesilmen O, et al. New coagulant agent (Ankaferd Blood Stopper) for open hemorrhages in hemophilia with inhibitor. Clin Appl Thromb Hemost 2010; 16:705-707.
33. Saribas Z, Sener B, Haznedaroglu IC, Hascelik G, Kirazli S, Goker H. Antimicrobial activity of Ankaferd Blood StopperA (R) against nosocomial bacterial pathogens. Cent Eur J Med 2010; 5:198-202.
34. Turhan N, Kurt M, Shorbagi A, Akdogan M, Haznedaroglu IC. Topical Ankaferd Blood Stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization. Am J Gastroenterol 2009; 104:2874-2877.
35. Karabiyik A, Gulec S, Yilmaz E, Haznedaroglu IC, Akar N. Reversible protease-activated receptor 1 down-regulation mediated by Ankaferd Blood Stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells. Clin Appl Thromb Hemost 2010.